iCoreConnect Inc. (ICCT)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
iCoreConnect Inc. (ICCT) trades at $0.00 with AI Score 55/100 (Grade B). iCoreConnect Inc. is a cloud-based software company specializing in HIPAA compliant solutions for healthcare providers. Market cap: $5,365, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for ICCT: ICCT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ICCT against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
ICCT: 3/7 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →iCoreConnect Inc. (ICCT) Healthcare & Pipeline Overview
iCoreConnect Inc. leverages cloud-based technology to provide HIPAA compliant software solutions for healthcare providers, enhancing operational efficiency and patient care through a comprehensive suite of services tailored to the needs of modern medical practices.
What Is the Investment Thesis for ICCT?
iCoreConnect Inc. operates in a rapidly evolving healthcare technology landscape, with a focus on HIPAA compliant SaaS solutions. The company's gross margin stands at 76.8%, indicating strong profitability potential despite a current profit margin of -289.9%. Key growth catalysts include the increasing demand for electronic health solutions, the expansion of telehealth services, and regulatory pressures for compliance, which are expected to drive adoption of iCoreConnect's products. The healthcare SaaS market is projected to grow significantly, providing iCoreConnect with opportunities to capture market share. However, investors may want to evaluate risks such as competitive pressures and the company's current financial instability, which may impact its ability to scale effectively in the near term.
Based on FMP financials and quantitative analysis
ICCT Key Highlights
- Gross margin of 76.8% indicates strong profitability potential.
- Market cap currently stands at $0.00B, reflecting early-stage growth.
- Profit margin of -289.9% highlights the need for operational improvements.
- Beta of -1.55 suggests high volatility relative to the market.
- No dividend yield as the company reinvests in growth initiatives.
Who Are ICCT's Competitors?
ICCT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CERN Cerner Corporation | $94.92 | +0.00% | 54 | |
| EPAY Bottomline Technologies, Inc. | $56.99 | +0.00% | 52 | |
| MDRX Veradigm Inc. | $5.09 | +1.90% | $865.28M | 50 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| SLGCW SomaLogic, Inc. | $0.09 | -28.33% | $396.23M | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ICCT's Key Strengths?
- Strong gross margin of 76.8% indicates potential for profitability.
- Comprehensive suite of HIPAA compliant products enhances market appeal.
- Established brand presence and industry experience since 1992.
What Are ICCT's Weaknesses?
- Current profit margin of -289.9% highlights financial instability.
- Limited market capitalization may restrict growth opportunities.
- Dependence on a small number of key products for revenue.
What Could Drive ICCT Stock Higher?
- Expansion of telehealth services expected to drive revenue growth in the next 1-2 years.
- Increasing demand for HIPAA compliant solutions as healthcare regulations tighten.
- Potential partnerships with major healthcare providers to enhance product adoption.
What Are the Key Risks for ICCT?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger healthcare software providers.
- Financial instability indicated by a negative profit margin.
- Regulatory changes that could impact operational costs and compliance.
What Are the Growth Opportunities for ICCT?
- Expansion of Telehealth Services: The telehealth market is projected to reach $459.8 billion by 2030, driven by increasing demand for remote healthcare solutions. iCoreConnect can leverage its existing software to provide integrated telehealth services, enhancing patient engagement and accessibility while generating additional revenue streams.
- Increased Regulatory Compliance: As healthcare regulations become more stringent, the demand for compliant solutions is expected to rise. iCoreConnect's focus on HIPAA compliance positions it well to capture market share as healthcare providers seek reliable partners to ensure adherence to evolving regulations.
- Integration of AI and Machine Learning: The integration of AI and machine learning in healthcare is set to revolutionize patient care and operational efficiency. iCoreConnect can enhance its product offerings by incorporating AI-driven analytics, providing healthcare providers with actionable insights to improve patient outcomes and streamline administrative processes.
- Partnerships with Healthcare Providers: Forming strategic partnerships with healthcare providers can expand iCoreConnect's reach and enhance its product offerings. Collaborations with larger healthcare systems can lead to increased adoption of its solutions and drive revenue growth through shared resources and expertise.
- Market Penetration in Emerging Markets: As healthcare systems in emerging markets continue to evolve, there is a growing demand for affordable and compliant healthcare solutions. iCoreConnect has the opportunity to expand its services internationally, tapping into new customer bases and diversifying its revenue streams.
What Opportunities Does ICCT Have?
- Growing demand for telehealth solutions presents expansion potential.
- Increasing regulatory compliance needs drive market growth.
- Potential for strategic partnerships to enhance service offerings.
What Threats Does ICCT Face?
- Intense competition from established players in the healthcare software market.
- Rapid technological changes may require continuous innovation.
- Regulatory changes could impact operational processes and costs.
What Are ICCT's Competitive Advantages?
- Strong focus on HIPAA compliance differentiates iCoreConnect from competitors.
- Diverse product offerings cater to various needs within the healthcare sector.
- Established reputation in the industry enhances customer trust and loyalty.
What Does ICCT Do?
Founded in 1992, iCoreConnect Inc. is a cloud-based software and technology company headquartered in Ocoee, Florida. Originally known as iMedicor, Inc., the company rebranded to iCoreConnect in June 2017 to reflect its focus on innovative healthcare solutions. iCoreConnect specializes in providing Health Insurance Portability and Accountability Act (HIPAA) compliant software as a service (SaaS) to healthcare providers across the United States. The company’s extensive product lineup includes iCoreRx, an electronic prescription software; iCorePDMP, which checks patients' Prescription Drug Monitoring Program history; and iCoreVerify, a solution for insurance eligibility verification. Additional offerings include iCoreHuddle, which reveals revenue potential for each patient; iCoreCodeGenius, a medical coding reference tool; and iCoreClaims for claims processing. iCoreConnect also provides secure email solutions, cloud backup services, payment processing, and IT managed services. With a workforce of 67 employees, iCoreConnect is positioned to address the growing demand for compliance and efficiency in healthcare operations, offering a comprehensive suite of tools designed to improve patient care and streamline administrative tasks.
What Products and Services Does ICCT Offer?
- Develops cloud-based software solutions for healthcare providers.
- Offers HIPAA compliant electronic prescription software.
- Provides tools for insurance eligibility verification.
- Delivers secure email solutions for healthcare professionals.
- Facilitates patient payment processing and revenue cycle tracking.
- Offers IT managed services to enhance operational efficiency.
How Does ICCT Make Money?
- Generates revenue through subscription fees for its SaaS products.
- Offers tiered pricing models based on the size and needs of healthcare providers.
- Provides additional services such as IT support and consulting for an added fee.
What Industry Does ICCT Operate In?
The healthcare information services industry is experiencing significant growth, driven by the increasing digitization of patient records and the need for compliance with regulations such as HIPAA. The market for healthcare software solutions is expected to expand as providers seek to enhance operational efficiency and improve patient outcomes. iCoreConnect Inc. is well-positioned within this landscape, offering a comprehensive suite of solutions that address both compliance and operational needs. The competitive landscape includes various players, but iCoreConnect's focus on HIPAA compliance and its diverse product offerings provide a unique advantage in meeting the specific needs of healthcare providers.
Who Are ICCT's Key Customers?
- Healthcare providers including hospitals and clinics.
- Pharmacies utilizing electronic prescription services.
- Insurance companies requiring compliance solutions.
How iCoreConnect Inc. Is Valued
iCoreConnect Inc. carries a market capitalization of 5K, placing it in the micro-cap category. Relative to its peer group, ICCT's quantitative score of 55/100 is roughly in line with the peer average of 59/100.
Company Profile
iCoreConnect Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Ocoee, US. The company is led by CEO Adam V. Chambers. ICCT has traded publicly since 2023.
F-Score 3/9Financial Health
iCoreConnect Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Net sellingInsider Activity
The most recent 12 insider filings for iCoreConnect Inc. break down as 4 sales and 8 purchases. On net that is roughly 43K shares disposed (about $62K), a signal worth weighing alongside the fundamentals.
ICCT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's growth trajectory, indicating that those closest to the business believe in its potential.
- Community sentiment has shifted positively, with many discussions highlighting the innovative solutions iCoreConnect offers in the healthcare sector.
- New partnerships and collaborations have been announced, which could enhance market reach and operational capabilities.
- Increased media coverage has spotlighted iCoreConnect's advancements, generating heightened interest from potential investors and stakeholders.
Bear Case
- Concerns about market competition have emerged, with analysts noting that similar companies are rapidly gaining traction in the same space.
- Some community members express skepticism about the scalability of iCoreConnect's solutions, questioning whether they can meet growing demand.
- Recent earnings reports have shown mixed results, leading to uncertainty about the company's financial health moving forward.
- The stock's volatility has raised red flags for some investors, suggesting potential risks that could deter new capital inflow.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ICCT Latest News
No recent news available for ICCT.
ICCT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ICCT.
Price Targets
Wall Street price target analysis for ICCT.
ICCT MoonshotScore
What does this score mean?
The MoonshotScore rates ICCT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Adam V. Chambers
CEO
Adam V. Chambers has a robust background in technology and healthcare management. He has been instrumental in leading iCoreConnect Inc. since its rebranding in 2017, focusing on enhancing product offerings and expanding market reach. His experience includes various leadership roles in technology firms, where he honed his skills in strategic planning and operational efficiency.
Track Record: Under Adam's leadership, iCoreConnect has successfully rebranded and expanded its product suite, positioning the company to better serve the evolving needs of healthcare providers. His strategic decisions have led to increased visibility in the market and a stronger focus on compliance and patient care solutions.
ICCT OTC Market Information
The OTC Other tier includes companies that do not meet the requirements for more stringent OTC tiers or major exchanges like NYSE or NASDAQ. This tier allows for broader access to investors but may involve less regulatory oversight and lower liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower regulatory oversight compared to stocks listed on major exchanges.
- Potential for higher volatility and price fluctuations.
- Limited financial information available for thorough analysis.
- Review the company's financial statements and disclosures.
- Assess the competitive landscape and market position.
- Evaluate management's track record and strategic vision.
- Consider the company's growth potential and market trends.
- Examine any potential legal or regulatory issues.
- Established company history since 1992.
- Rebranding to iCoreConnect reflects a strategic focus.
- Diverse product offerings indicate operational stability.
What Investors Ask About iCoreConnect Inc. (ICCT) — Healthcare
What does iCoreConnect Inc. do?
iCoreConnect Inc. provides a range of HIPAA compliant cloud-based software solutions designed for healthcare providers. Their offerings include electronic prescription software, insurance eligibility verification tools, secure email solutions, and revenue cycle management services, all aimed at enhancing operational efficiency and patient care.
What are the main risks for ICCT?
ICCT faces several risks, including intense competition from established healthcare software providers, which could impact market share. Additionally, the company’s current financial instability, as indicated by its negative profit margin, poses a risk to its operational sustainability. Regulatory changes may also affect compliance costs and operational processes.
How does iCoreConnect Inc. navigate regulatory approval processes?
iCoreConnect Inc. navigates regulatory approval processes by ensuring that all its products meet the stringent requirements set forth by the Health Insurance Portability and Accountability Act (HIPAA). The company employs compliance experts to oversee product development and maintain adherence to evolving regulations, thereby minimizing the risk of non-compliance.
What are the key factors to evaluate for ICCT?
iCoreConnect Inc. (ICCT) holds an AI score of 55/100 (moderate). Not financial advice.
How frequently does ICCT data refresh on this page?
ICCT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ICCT's recent stock price performance?
iCoreConnect Inc. (ICCT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong gross margin of 76.8% indicates potential for profitability. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ICCT overvalued or undervalued right now?
Valuing iCoreConnect Inc. (ICCT) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ICCT?
Before investing in iCoreConnect Inc. (ICCT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data based on available information; financial metrics may not fully reflect current market conditions.